By Counterforce Health Team in Besponsa (inotuzumab ozogamicin) —

How to Get Besponsa (Inotuzumab Ozogamicin) Covered by Blue Cross Blue Shield in Michigan: PA Forms, Appeal Scripts & Cost Assistance

Answer Box: Getting Besponsa Covered in Michigan

To get Besponsa (inotuzumab ozogamicin) covered by Blue Cross Blue Shield of Michigan (BCBSM): Your oncologist must submit prior authorization with CD22-positive lab results, diagnosis codes for relapsed/refractory B-cell ALL, and documentation of prior therapy failures. If denied, you have 127 days to file an external appeal with Michigan DIFS. Commercially insured patients may qualify for Pfizer's $0 copay program.

First step today: Ask your oncologist's office to gather your CD22+ pathology report and submit the BCBSM prior authorization request through their provider portal.

Table of Contents

  1. What Drives Besponsa Costs
  2. Investigating Your BCBS Michigan Benefits
  3. Prior Authorization Requirements
  4. Financial Assistance Options
  5. Formulary Tier Exceptions
  6. Specialty Pharmacy Coordination
  7. Appeals Process in Michigan
  8. Annual Renewal Planning
  9. Scripts for Key Conversations
  10. Common Denial Reasons & Solutions
  11. FAQ

What Drives Besponsa Costs

Besponsa (inotuzumab ozogamicin) is a specialty oncology drug with a wholesale acquisition cost of approximately $8,700 per 0.9-mg vial. Your out-of-pocket costs depend on several factors:

Benefit Design Basics:

  • Formulary tier placement: BCBS Michigan typically places Besponsa on specialty tier, resulting in 20-40% coinsurance rather than fixed copays
  • Prior authorization: Required for all BCBS Michigan plans
  • Site of care restrictions: May require specialty pharmacy or medical benefit administration
  • Annual deductible: Specialty tier drugs often apply to your medical deductible first

Coverage Variables:

  • Commercial vs. Medicare Advantage plans have different formularies
  • Individual vs. employer group plans may have varying specialty tiers
  • Some plans cap specialty drug costs at $200-500 monthly maximums
Tip: Besponsa is administered intravenously in cycles, so total treatment costs depend on your prescribed regimen and response duration.

Investigating Your BCBS Michigan Benefits

Before starting treatment, gather this information by calling the member services number on your insurance card:

Questions to Ask BCBS Michigan:

  1. "Is Besponsa on my plan's formulary, and what tier?"
  2. "What's my specialty drug coinsurance percentage and annual out-of-pocket maximum?"
  3. "Does my plan require prior authorization for Besponsa?"
  4. "Are there site-of-care requirements or preferred specialty pharmacies?"
  5. "What's my current deductible status for this plan year?"

Information to Record:

  • Plan name and member ID
  • Formulary tier and coinsurance percentage
  • Deductible amounts (medical vs. pharmacy)
  • Prior authorization requirements
  • Specialty pharmacy network restrictions
  • Customer service reference number from your call

Key Resources:

Prior Authorization Requirements

BCBS Michigan requires prior authorization for Besponsa with specific documentation requirements:

Required Documentation:

  • CD22-positive status: Laboratory or pathology report confirming CD22+ B-cell precursor ALL
  • FDA-approved indication: Relapsed or refractory B-cell precursor acute lymphoblastic leukemia in adults
  • Prior therapy history: Documentation of previous treatments and outcomes
  • Clinical notes: Supporting medical necessity and treatment goals
  • Diagnosis codes: ICD-10 codes for your specific ALL subtype

Submission Process:

  1. Only your provider can submit the prior authorization request
  2. Submissions go through the BCBS Michigan provider portal
  3. Standard review takes 5-7 business days
  4. Expedited reviews available for urgent cases (24-48 hours)
Note: Missing CD22+ documentation is a common denial reason. Ensure your pathology report clearly states CD22-positive status.

Clinician Corner: Medical Necessity Letter Checklist

Essential Elements for Approval:

  • Patient demographics and diagnosis with ICD-10 codes
  • CD22-positive laboratory confirmation with date
  • Detailed prior treatment history (chemotherapy regimens, responses, failures)
  • Clinical rationale citing FDA labeling and treatment guidelines
  • Hepatotoxicity risk assessment and monitoring plan
  • Dosing schedule aligned with FDA-approved regimen
  • Treatment goals and expected outcomes

Guideline References to Include:

Financial Assistance Options

Pfizer Copay Assistance Program

Eligibility for Michigan Patients:

  • Must have commercial insurance (not Medicare, Medicaid, or TRICARE)
  • Prescription for FDA-approved Besponsa indication
  • U.S. resident

Benefits:

  • Pay as little as $0 per month for Besponsa
  • Program covers difference between insurance copay and program maximum

How to Apply:

  1. Visit Pfizer Copay Portal
  2. Complete online enrollment (patient, provider, or pharmacy can enroll)
  3. Receive copay card for pharmacy use

Alternative for Government Insurance:

Additional Resources

Foundation Support:

  • Leukemia & Lymphoma Society Patient Aid Program
  • CancerCare Co-Payment Assistance Foundation
  • Patient Advocate Foundation Co-Pay Relief Program

State Programs:

  • Michigan may offer additional assistance through Department of Health and Human Services programs

Formulary Tier Exceptions

If Besponsa is non-formulary or placed on a high-cost tier, request a formulary exception:

When to Request:

  • Drug is not covered (non-formulary)
  • Placed on highest specialty tier with prohibitive costs
  • Formulary alternatives are contraindicated or ineffective

Exception Request Process:

  1. Provider submits formal exception request through BCBS Michigan portal
  2. Include comprehensive medical necessity letter
  3. Document why formulary alternatives won't work
  4. Provide supporting literature and clinical evidence

Required Documentation:

  • Letter of medical necessity from oncologist
  • CD22+ pathology results
  • Prior treatment failure documentation
  • Contraindication evidence for formulary alternatives
  • Published clinical studies supporting Besponsa use

Timeline:

  • Standard exception reviews: 15 business days
  • Expedited reviews available for urgent medical situations

Specialty Pharmacy Coordination

Pharmacy Network Requirements

BCBS Michigan typically requires specialty drugs like Besponsa to be dispensed through:

  • Designated specialty pharmacy networks
  • Hospital or clinic-based pharmacies for buy-and-bill
  • Specific mail-order specialty providers

Coordination Tips:

  1. Verify your plan's specialty pharmacy network before treatment
  2. Confirm pharmacy accepts your specific BCBS Michigan plan
  3. Ensure pharmacy has prior authorization on file
  4. Schedule delivery timing with treatment appointments

Site of Care Considerations

Besponsa is administered intravenously, requiring:

  • Oncology clinic or hospital outpatient setting
  • Trained healthcare providers for administration
  • Monitoring capabilities for infusion reactions
  • Emergency response protocols

Appeals Process in Michigan

Internal Appeals with BCBS Michigan

First Level:

  • Submit appeal within 180 days of denial
  • Include additional clinical documentation
  • Request peer-to-peer review with medical director

Required Documentation:

  • Copy of denial letter
  • Updated medical records
  • Additional supporting literature
  • Physician letter addressing denial reasons

Michigan DIFS External Review

If BCBS Michigan upholds the denial, you can appeal to Michigan Department of Insurance and Financial Services (DIFS):

Timeline:

  • Must file within 127 days of final BCBS denial
  • Standard review: up to 60 days
  • Expedited review: 72 hours (with physician urgency letter)

How to File:

  1. Complete DIFS External Review Request form
  2. Submit online or mail to DIFS
  3. Include all supporting medical documentation

Contact Information:

Important: DIFS external reviews are binding on insurance companies. If approved, BCBS Michigan must cover the treatment.

Annual Renewal Planning

What Changes Each Year:

  • Formulary tier placements may shift
  • Prior authorization requirements can be updated
  • Copay assistance program terms may change
  • Specialty pharmacy networks might be modified

Renewal Reminders:

  • Review plan formulary changes each January
  • Re-enroll in Pfizer copay assistance annually
  • Confirm specialty pharmacy network participation
  • Budget for potential out-of-pocket changes

Scripts for Key Conversations

Calling BCBS Michigan Member Services

"Hi, I'm calling about coverage for Besponsa, spelled B-E-S-P-O-N-S-A, for my acute lymphoblastic leukemia. Can you tell me if this drug is on my formulary, what tier it's on, and whether prior authorization is required? My member ID is [number]."

Provider Office: Requesting Peer-to-Peer Review

"We'd like to request a peer-to-peer review for our Besponsa prior authorization denial. The patient has CD22-positive relapsed ALL and has failed standard therapies. Can you schedule a call between our oncologist and your medical director?"

Pharmacy Coordination

"I need to fill a specialty prescription for Besponsa. Can you confirm you're in-network with Blue Cross Blue Shield of Michigan and that you have the prior authorization on file? When can we schedule delivery to coordinate with my treatment appointment?"

Common Denial Reasons & Solutions

Denial Reason How to Overturn
CD22+ status not documented Submit pathology report clearly showing CD22-positive results
Not appropriate line of therapy Provide detailed prior treatment history and failure documentation
Experimental/investigational Cite FDA approval and established clinical guidelines
Hepatotoxicity concerns Include comprehensive risk assessment and monitoring plan
Alternative therapies available Document contraindications or failures with formulary options

FAQ

How long does BCBS Michigan prior authorization take? Standard reviews take 5-7 business days. Expedited reviews for urgent cases can be completed in 24-48 hours.

What if Besponsa isn't on my formulary? Request a formulary exception with comprehensive medical necessity documentation. Your oncologist must demonstrate why formulary alternatives won't work.

Can I get expedited appeals in Michigan? Yes, both BCBS Michigan and DIFS offer expedited reviews for urgent medical situations requiring physician documentation of urgency.

Does the Pfizer copay program work with all BCBS Michigan plans? The program works with commercial BCBS Michigan plans but not Medicare Advantage or Medicaid plans due to federal regulations.

What happens if DIFS overturns my denial? DIFS external review decisions are binding. BCBS Michigan must cover the treatment as directed by the independent review organization.

How do I prove medical necessity for relapsed ALL? Include CD22+ pathology results, prior treatment records showing failure or intolerance, current disease status, and physician letter citing treatment guidelines.

From Our Advocates: We've seen patients successfully overturn Besponsa denials by ensuring their CD22-positive status was clearly documented in pathology reports and by providing comprehensive prior treatment histories. The key is thorough documentation from the start – it saves time and increases approval chances significantly.

Counterforce Health specializes in helping patients, clinicians, and specialty pharmacies turn insurance denials into successful appeals. Our platform analyzes denial letters, identifies specific coverage criteria, and generates evidence-backed appeals tailored to each payer's requirements – helping you navigate complex prior authorization processes more effectively.

For additional support navigating your Besponsa coverage journey, Counterforce Health provides tools and resources to strengthen your appeal documentation and improve approval outcomes.

Sources & Further Reading

Disclaimer: This information is for educational purposes only and does not constitute medical or legal advice. Coverage policies vary by plan and change frequently. Always verify current requirements with your specific insurance plan and consult your healthcare provider for medical decisions. For personalized assistance with Michigan insurance issues, contact DIFS at 877-999-6442.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.